Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 2 of 2
Full-Text Articles in Pathology
Labrad : Vol 48, Issue 1 - July 2023, Aga Khan University Hospital, Karachi
Labrad : Vol 48, Issue 1 - July 2023, Aga Khan University Hospital, Karachi
LABRAD
- Editorial
- Articles
- Toxicology In Public Health: Mitigating Risk, Fostering Well-Being
- Predictive And Prognostic Biomarkers in Histopathology
- Cancer Registry and Public Health Surveillance - Role of Pathologists
- Diagnosis of Celiac Disease DQA1*02,05; DQB1*02,03:02 (DQ2&DQ8) in patients
- Magnifying The Clinical Value of Expert Review and Reassessment
- Urine Cytology: A Screening and Surveillance Test
- An Overview of Convalescent Plasma for The Treatment of COVID-19
- Role of Imaging in Public Health Care
- Microsatellite Instability (MSI) Testing
- MRI Liver with Hepatocyte-Specific Contrast Agent
- Basics and Role of Cytopathology
- Bone Tumors: From Timely Diagnosis to Improved Patient Outcome
- Differentiating Between Dengue Fever and Malaria Using The …
Immunohistochemistry For The Proliferation Markers Ki67 And Phh3 In Cell Block Material Of Basaloid Salivary Gland Neoplasms Is Predictive Of Malignancy, Robert Post, Zach Breslin, Yanki Yarman, Stacey Gargano
Immunohistochemistry For The Proliferation Markers Ki67 And Phh3 In Cell Block Material Of Basaloid Salivary Gland Neoplasms Is Predictive Of Malignancy, Robert Post, Zach Breslin, Yanki Yarman, Stacey Gargano
Department of Pathology, Anatomy, and Cell Biology Posters
Background: Basaloid salivary gland neoplasms (BSGNs) are notoriously difficult to classify in fine needle aspiration (FNA) specimens due to the morphologic overlap shown by the various benign and malignant entities in this category1,2,3. Adenoid cystic carcinoma (AdCC) represents a particular diagnostic challenge, as it typically shows low grade cytologic features despite its aggressive clinical behavior and need for more extensive surgery4. We examined whether the proliferation markers Ki67 and PHH3 could help predict malignancy in BSGNs, thus improving diagnostic accuracy and optimizing patient care.